Search research articles
Contact Us
Filters
Showing results (231-240 of 322) with videos related to
Page
of 33
Sort By:
BJU International
|
November 28, 2008
Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial
Robert L Grubb, Paul F Pinsky, Robert T Greenlee, et al.
British Journal of Cancer
|
June 22, 2013
Tumour morphology predicts PALB2 germline mutation status
Z L Teo, E Provenzano, G S Dite, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
September 7, 2011
Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status
Steven J Skates, Phuong Mai, Nora K Horick, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 7, 2016
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015
Mary B Daly, Robert Pilarski, Jennifer E Axilbund, et al.
Plos One
|
March 26, 2013
Soluble guanylate cyclase α1-deficient mice: a novel murine model for primary open angle glaucoma
Emmanuel S Buys, Yu-Chieh Ko, Clemens Alt, et al.
Nature Genetics
|
May 29, 2007
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
David J Hunter, Peter Kraft, Kevin B Jacobs, et al.
BMC Health Services Research
|
June 3, 2021
Comparing models of delivery for cancer genetics services among patients receiving primary care who meet criteria for genetic evaluation in two healthcare systems: BRIDGE randomized controlled trial
Kimberly A Kaphingst, Wendy Kohlmann, Rachelle Lorenz Chambers, et al.
Nature Communications
|
February 7, 2018
Publisher Correction: Combating subclonal evolution of resistant cancer phenotypes
Samuel W Brady, Jasmine A McQuerry, Yi Qiao, et al.
Nature Communications
|
November 3, 2017
Combating subclonal evolution of resistant cancer phenotypes
Samuel W Brady, Jasmine A McQuerry, Yi Qiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2024
Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in <i>BRCA1</i> and <i>BRCA2</i>
Kelly-Anne Phillips, Joanne Kotsopoulos, Susan M Domchek, et al.
Page
of 33
Search research articles
Search
Showing results (231-240 of 322) with videos related to
Sort By:
Page
of 33
BJU International
|
November 28, 2008
Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial
Robert L Grubb, Paul F Pinsky, Robert T Greenlee, et al.
British Journal of Cancer
|
June 22, 2013
Tumour morphology predicts PALB2 germline mutation status
Z L Teo, E Provenzano, G S Dite, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
September 7, 2011
Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status
Steven J Skates, Phuong Mai, Nora K Horick, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 7, 2016
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015
Mary B Daly, Robert Pilarski, Jennifer E Axilbund, et al.
Plos One
|
March 26, 2013
Soluble guanylate cyclase α1-deficient mice: a novel murine model for primary open angle glaucoma
Emmanuel S Buys, Yu-Chieh Ko, Clemens Alt, et al.
Nature Genetics
|
May 29, 2007
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
David J Hunter, Peter Kraft, Kevin B Jacobs, et al.
BMC Health Services Research
|
June 3, 2021
Comparing models of delivery for cancer genetics services among patients receiving primary care who meet criteria for genetic evaluation in two healthcare systems: BRIDGE randomized controlled trial
Kimberly A Kaphingst, Wendy Kohlmann, Rachelle Lorenz Chambers, et al.
Nature Communications
|
February 7, 2018
Publisher Correction: Combating subclonal evolution of resistant cancer phenotypes
Samuel W Brady, Jasmine A McQuerry, Yi Qiao, et al.
Nature Communications
|
November 3, 2017
Combating subclonal evolution of resistant cancer phenotypes
Samuel W Brady, Jasmine A McQuerry, Yi Qiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2024
Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in <i>BRCA1</i> and <i>BRCA2</i>
Kelly-Anne Phillips, Joanne Kotsopoulos, Susan M Domchek, et al.
Page
of 33